DOXYCIN TAB 100MG 100 MG
DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG · DIN 00860751 · LABORATOIRE RIVA INC.
Health Canada status: MARKETED
What is DOXYCIN TAB 100MG?
DOXYCIN TAB 100MG 100 MG contains DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00860751, held by LABORATOIRE RIVA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1989. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DOXYCIN TAB 100MG used for?
Pneumonia, respiratory tract infections, genitourinary tract infections (including Chlamydia), skin/soft tissue infections, and gastro-intestinal infections caused by susceptible organisms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00860751 |
|---|---|
| Brand name | DOXYCIN TAB 100MG |
| Generic / active ingredient | DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG |
| Manufacturer | LABORATOIRE RIVA INC. |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01AA02 DOXYCYCLINE |
| AHFS class | 08:12.24 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1989 |
| Original market date | 1989-12-31 00:00:00 |
How is it administered?
Adults: 200 mg loading dose on day 1, then 100 mg daily. Severe infections: 200 mg daily. Take with full glass of water while upright; do not take at bedtime.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15-30°C), protected from light and excessive humidity.
How is it supplied?
Tablets: Bottles of 100 and 300. Capsules: Bottles of 100.
Contraindications
Hypersensitivity to doxycycline or tetracyclines; myasthenia gravis; concurrent use of isotretinoin.
Warnings and precautions
Risk of permanent tooth discoloration in children <8 and during pregnancy/lactation. Esophageal lesions if taken incorrectly. Clostridium difficile-associated disease (CDAD). Photosensitivity.
What can be used instead?
Other Canadian products sharing ATC code J01AA02 DOXYCYCLINE. 14 of 43 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-DOXYCYCLINE | 100 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02556928 |
| APO-DOXY CAP 100MG | 100 MG | CAPSULE | APOTEX INC | MARKETED | DIN 00740713 |
| APO-DOXY TABS 100MG | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 00874256 |
| APO-DOXYCYCLINE MR | 40 MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02512645 |
| APPRILON | 40 MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | GALDERMA CANADA INC | MARKETED | DIN 02375885 |
| DOXYTAB | 100 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00887064 |
| JAMP DOXYCYCLINE CAPSULES | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02528940 |
| JAMP DOXYCYCLINE TABLETS | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02554372 |
| M-DOXYCYCLINE | 100 MG | TABLET | MANTRA PHARMA INC | MARKETED | DIN 02543478 |
| NRA-DOXYCYCLINE | 100 MG | TABLET | NORA PHARMA INC | MARKETED | DIN 02558505 |
Who else supplies DOXYCYCLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DOXYCYCLINE appears in 306 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.